Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors
Titel:
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors
Auteur:
Molife, L Rhoda Yan, Li Vitfell-Rasmussen, Joanna Zernhelt, Adriane M Sullivan, Daniel M Cassier, Philippe A Chen, Eric Biondo, Andrea Tetteh, Ernestina Siu, Lillian L Patnaik, Amita Papadopoulos, Kyriakos P de Bono, Johann S Tolcher, Anthony W Minton, Susan